Background-Sustained ventricular tachycardia (VT) and fibrillation (VF) occ
ur in up to 20% of patients with acute myocardial infarction (MI) and have
been associated with a poor prognosis. The relationships among the type of
arrhythmia (VT versus VF or both), time of VT/VF occurrence, use of thrombo
lytic agents, and eventual outcome are unclear.
Methods and Results-In the GUSTO-I study, we examined variables associated
with the occurrence of VT/VF and its impact on mortality. Of the 40 895 pat
ients with ventricular arrhythmia data, 4188 (10.2%) had sustained VT, VF,
or both. Older age, systemic hypertension, previous MI, Killip class, anter
ior infarct, and depressed ejection fraction were associated with a higher
risk of sustained VT and VF (P<0.001). In-hospital and 30-day mortality rat
es were higher among patients with sustained VT/VF than among patients with
out sustained ventricular arrhythmias (P<0.001). Both early (<2 days) and l
ate (>2 days) occurrences of sustained VT and VF were associated with a hig
her risk of later mortality (P<0.001). In addition, patients with both VT a
nd VF had worse outcomes than those with either VT or VF alone (P<0.001). A
mong patients who survived hospitalization, no significant difference was f
ound in 30-day mortality between the VT/VF and no VT/VF groups. However, af
ter 1 year, the mortality rate was significantly higher in the VT alone and
VT/VF groups (P<0.0001).
Conclusions-Despite the use of thrombolytic therapy, both early and late oc
currences of sustained VT or VF continue to have a negative impact on patie
nt outcome; patients with both VT and VF had the worst outcome; and among p
atients who survived hospitalization, the 1-year mortality rate was signifi
cantly higher in those who experienced VT alone or VT and VF.